36
Total investments
31
Early stage
2
Mid stage
0
Late stage
14y
Years active
Portfolio
36 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor & Strategic Advisor
2022
One mission — 100 healthy years.
160+ lab tests and advanced MRI & CT scans, with data-driven insights.
One membership designed to help you look for early signs of potential health conditions and stay proactive.
Start with 100+ lab tests, followed by a 60+ test follow-up after 3–6 months — 5x more than the average physical.
Results tracked over time in one secure place.
Advanced imaging that looks for early signs across key areas of the body, alongside testing for heart health, hormones, metabolic function, and more.
Data-driven insights to help you make sense of your results.
Starting at $1/day.
Investor
2021
Index Health is a precision medicine company that uses big data, personalization, and specialized medical staff to most effectively treat disease and create longevity. As were trending currently, we believe that by using our medicine and technology, we can eliminate all disease by 2040.
Investor
2021
Tiny Health is the leading microbiome health platform for people tackling chronic conditions or looking to optimize overall health.
Tiny Health’s Gut Health Test is the first-ever at-home gut microbiome test for pregnant moms and babies to use shotgun metagenomics, and the company now also offers tests for older children and adults, as well as Vaginal Health Tests.
To date, 30,000 families have trusted Tiny Health to correct imbalances in the gut and vaginal microbiome, and optimize their lifelong health. By taking evidence-based action steps from a dietary, supplement and lifestyle based on personalized results, weve helped people reduce severe symptoms and in some cases even reverse chronic conditions.
Tiny Healths team includes top scientists, physicians, and microbiologists from Mayo Clinic, Johns Hopkins, Stanford, WashU, Cornell, and Harvard Medical School. For more information, visit tinyhealth.com and poweredbytiny.com
Investor
2021
Tomorrow.bio is advancing biostasis by providing high-quality cryopreservation services in the heart of Europe.
As the world’s fastest-growing cryopreservation company with 800+ members, our mission is simple: to enable people to choose how long they want to live.
Were optimistic about the future, the power of technology, and—above all—life itself. Our international team of doctors, engineers, and entrepreneurs is young, driven, and committed to making medical time travel a reality.
With a pricing model designed for transparency, flexibility, and long-term value, we’re making cryopreservation more accessible than ever.
Join us—and get ready for tomorrow 💙
https://member.tomorrow.bio/signup/start
Investor
2021
At HOLY our vision is to become the most loved soft drink brand of the 21st century.
Traditionally, soft drinks fall into two categories: popular brands that are tasty but unhealthy, whereas those with a strong health focus usually lack great taste.
At HOLY, we break the status quo. With our product lines HOLY Energy®, Iced Tea®, Hydration®, and Milkshake®, you get great taste with a clear conscience. Zero sugar. Zero bullsh*t.
Since launching HOLY from our living room in 2021, we have built a loyal customer base of 2 Million+ across Europe and scaled profitably to more than €150m+ in sales, with a category-leading 4.6-star rating on Trustpilot and reviews.io.
And that’s just the beginning: Backed by the world’s leading consumer investors, our team of 150+ aims to disrupt the soft drink industry while creating a product and brand consumers truly love.
To join us in this mission and lets discuss how we can build a global consumer rocket ship together! 🚀
Investor
2021
MYNE Homes – Your dream holiday home, made accessible through Managed Co-Ownership
At MYNE Homes, we make owning a dream holiday home affordable and effortless through our innovative Managed Co-Ownership model – offering true real estate ownership, not timeshare.
Most holiday homes are only used 6–10 weeks per year, yet buyers are still expected to cover 100% of the purchase price and running costs. That simply doesn’t make sense.
With MYNE, 2 to 8 co-owners with complementary usage preferences share ownership of a carefully selected premium property. Each MYNE co-owner holds real equity in the home – starting from 1/8 up to 4/8 ownership shares. You only pay for what you actually use – without compromising on comfort, flexibility, or the holiday experience.
All MYNE homes are beautifully furnished by professional interior designers and managed with care by our expert team. Owners enjoy hassle-free stays with access to local concierge services and seamless digital management.
We believe in delivering both emotional and financial return. By combining smart technology, high-end service, and a unique ownership structure, MYNE is redefining what it means to own a holiday home.
Investor
Mar 2020
Easily deliver subscriber-exclusive content to your most passionate fans, get paid, and enjoy rich analytics on your business.
Investor
2020
Locad is the logistics engine enabling e-commerce brands to systematically store, pack, ship, and track orders across Asia-Pacific, GCC and the USA.
Our tech platform syncs inventory across online channels and organizes end-to-end order fulfillment through our reliable network of warehouses and shipping partners across Singapore, Malaysia, the Philippines, Thailand, Indonesia, China, Australia, the USA, Saudi Arabia, and UAE with more locations opening soon.
Hundreds of brands now have access to the Locad logistics engine, allowing faster shipping, reduced costs, and exponential growth. Equipped with the technology, infrastructure, and partners running on one integrated system, Locad is on a mission to propel every business forward.
Locad. All Systems Go.
Investor
2020
Alpas is the premier AI-powered sourcing intelligence solution. The company enables procurement to identify suppliers 10x faster. Alpas assists in finding and benchmarking suppliers for technical components and services.
Reduce your time spent on sourcing and significantly decrease purchasing costs with Alpas by automating manual, data-intensive workflows.
Investor
2020
NOVOS leverages science and data to create the best nutraceuticals to extend human lifespan.
We at NOVOS believe much more can be done to slow down aging through science, so we create the first supplements in the world that are:
• Based on the best available science
• Created with the world’s top experts in the aging field
• Use scientifically validated ingredients that extend lifespan in various organisms
• Focused on the 12 mechanisms of aging mechanisms to leverage synergistic effects
• Include ingredients shown to have beneficial effects on aging in humans
The result is NOVOS, the best longevity supplements available.
NOVOS’ scientific advisors are biochemists, geneticists and professors from Harvard, MIT, University of Liverpool, University of Washington, Salk Institute, and other universities & institutes around the world.
Our scientists have received honors that include Breakthroughs in Gerontology Award, an Alzheimer’s Association New Investigator Award, and an Ellison Medical Foundation New Scholar in Aging Award.
Each one of them is a pioneer in the longevity field and have been featured by 60 Minutes, TIME magazine, BBC, CNN, Science, Scientific American, Washington Post, New York Times, and countless other publications.
NOVOS is a Public Benefit Corporation (PBC). A portion of our profits and equity is donated to nonprofits in the longevity science space, like the 501(c)(3), Life Extension Advocacy Foundation (LEAF).
NOVOS also creates free content to educate people on how to live longer, healthier lives, even if they don’t use NOVOS, which you can find on our blog at NovosLabs.com.
Investor
Oct 2019
Hopkins is a legal technology company specialized on fighting for consumer rights at scale.
We rethink the principles of legal execution from the ground up - with a strong focus on software, data, and interdisciplinary collaboration between engineers, lawyers, and legal strategists. With our technology, we focus on algorithms predicting case outcomes and optimal negotiation strategies, as well as tools augmenting Hopkins' lawyers to reach superior results on a regular basis.
Investor
2019
We are Myos - a well financed and strongly growing FinTech, founded in Berlin in 2018 by a team of experienced entrepreneurs. With our unique and disruptive risk model, we are breaking completely new ground: We use the transparency and availability of data on e-commerce platforms to take the future sales potential of retail products as a basis for financing decisions. In this way, we enable retailers worldwide to grow fully digitally and flexibly.
Investor
2019
Luca Faloni is a vertically integrated menswear brand established online in 2014. We deliver superior craftsmanship and create a true Made in Italy proposition available directly to our clients worldwide.
Our promise is to source the finest materials from the most prestigious Italian producers and disregard seasonal collections in favour of product longevity. For each design, we partner with the most skilled Italian artisans, who have been honouring their craft for generations.
Discover more at www.lucafaloni.com
Investor
2019
We are Myos - a well financed and strongly growing FinTech, founded in Berlin in 2018 by a team of experienced entrepreneurs. With our unique and disruptive risk model, we are breaking completely new ground: We use the transparency and availability of data on e-commerce platforms to take the future sales potential of retail products as a basis for financing decisions. In this way, we enable retailers worldwide to grow fully digitally and flexibly.
Investor
2018
Zenyum is on a mission to help Asia smile more.
Were a consumer-focused healthcare brand that removes medical jargon, cancelled appointments, price variations and puts convenience at the centre of your smile journey. The result? Affordable dental treatment that actually works.
Founded in 2018 in Singapore, Zenyum provides Smile Cosmetics, produced under the highest quality standards. Led by a team of experienced tech entrepreneurs and doctors, we bring the highest level of care to our customers by partnering with experienced local dentists across Asia.
Zenyum operates in Singapore, Malaysia, Taiwan, Hong Kong, Japan, Thailand, Vietnam and Indonesia.
Show all 36 investments ↓
Experience · 43 entries
All (43)
Investments (36)
Founder (6)
Board (1)
2022
Investor & Strategic Advisor
2022
One mission — 100 healthy years.
160+ lab tests and advanced MRI & CT scans, with data-driven insights.
One membership designed to help you look for early signs of potential health conditions and stay proactive.
Start with 100+ lab tests, followed by a 60+ test follow-up after 3–6 months — 5x more than the average physical.
Results tracked over time in one secure place.
Advanced imaging that looks for early signs across key areas of the body, alongside testing for heart health, hormones, metabolic function, and more.
Data-driven insights to help you make sense of your results.
Starting at $1/day.
2021
Investor
2021
Index Health is a precision medicine company that uses big data, personalization, and specialized medical staff to most effectively treat disease and create longevity. As were trending currently, we believe that by using our medicine and technology, we can eliminate all disease by 2040.
Investor
2021
Tiny Health is the leading microbiome health platform for people tackling chronic conditions or looking to optimize overall health.
Tiny Health’s Gut Health Test is the first-ever at-home gut microbiome test for pregnant moms and babies to use shotgun metagenomics, and the company now also offers tests for older children and adults, as well as Vaginal Health Tests.
To date, 30,000 families have trusted Tiny Health to correct imbalances in the gut and vaginal microbiome, and optimize their lifelong health. By taking evidence-based action steps from a dietary, supplement and lifestyle based on personalized results, weve helped people reduce severe symptoms and in some cases even reverse chronic conditions.
Tiny Healths team includes top scientists, physicians, and microbiologists from Mayo Clinic, Johns Hopkins, Stanford, WashU, Cornell, and Harvard Medical School. For more information, visit tinyhealth.com and poweredbytiny.com
Investor
2021
Tomorrow.bio is advancing biostasis by providing high-quality cryopreservation services in the heart of Europe.
As the world’s fastest-growing cryopreservation company with 800+ members, our mission is simple: to enable people to choose how long they want to live.
Were optimistic about the future, the power of technology, and—above all—life itself. Our international team of doctors, engineers, and entrepreneurs is young, driven, and committed to making medical time travel a reality.
With a pricing model designed for transparency, flexibility, and long-term value, we’re making cryopreservation more accessible than ever.
Join us—and get ready for tomorrow 💙
https://member.tomorrow.bio/signup/start
Show all 43 entries ↓
Investment activity
2012–2022 · 36 investments
Recent (last 2 years)Earlier
